VASCULAR IMMUNOMOTHER T CELL LYMPHOMA

Clinical trials for VASCULAR IMMUNOMOTHER T CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new VASCULAR IMMUNOMOTHER T CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for VASCULAR IMMUNOMOTHER T CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested for Tough-to-Treat blood cancers

Disease control Ongoing

This early-stage study is testing an experimental drug called GNC-038 in adults with certain aggressive types of lymphoma that have returned or not responded to prior treatments. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors…

Matched conditions: VASCULAR IMMUNOMOTHER T CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

VASCULAR IMMUNOMOTHER T CELL LYMPHOMA

Get alerted when new VASCULAR IMMUNOMOTHER T CELL LYMPHOMA trials appear

New drug tested for Tough-to-Treat blood cancers